W. L. GORE & ASSOCIATES, INC. GORE® VIABAHN® VBX BALLOON EXPANDABLE ENDOPROSTHESIS; ILIAC COVERED STENT, ARTERIAL
|
Back to Search Results |
|
Catalog Number BXA095902A |
Device Problem
Appropriate Term/Code Not Available (3191)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 03/12/2024 |
Event Type
malfunction
|
Manufacturer Narrative
|
Cbas® heparin surface incorporates carmeda heparin manufactured from heparin sodium api, which is covalently bound to the device surface and is essentially non-eluting.H6 - code a27: device ovalization was observed during follow-up ct scans.Device remains patent and is still implanted with no intervention requirement.H6 - code b20: device remains implanted; therefore, direct product analysis was not possible.H6 - code c19: review of device manufacturing record history confirmed device met pre-release specifications.W.L.Gore & associates, inc.(gore) is submitting this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation.This report is based upon information obtained by gore, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Blank fields present on this report include required fields and fields determined to be not applicable.Blank required fields indicate that the information was not provided, was deemed unavailable or was not applicable.This report does not constitute an admission or a conclusion by fda, gore, or its associates that the device, gore or its associates caused or contributed to the event described in the report.In particular, this report does not constitute a legal admission by anyone that the product described in this report has any defects or has malfunctioned, as defined from a legal standpoint.These words are included in the report and are fixed items for selection created by the fda, to categorize the type of event solely for the purpose of reporting pursuant to part 803.This statement should be included with any information or report disclosed to the public under the freedom of information act.
|
|
Event Description
|
Information from a clinical study was received: on (b)(6) 2023, the patient underwent endovascular treatment of a thoracoabdominal aortic aneurysm using a gore® excluder® thoracoabdominal branch endoprosthesis (tambe) in the aaa1701 tambe pivotal study.Implanted were gore® viabahn® vbx balloon expandable endoprosthesis (vbx device), two devices in superior mesenteric artery (sma) in overlapped fashion, and one each in the left and right renal arteries.One vbx device was also implanted in the most proximal within the portal of the celiac artery.On (b)(6) 2023, a dissection of the distal celiac artery was observed.No intervention was reported.On (b)(6) 2023, the core lab imaging (cta) showed a dissection was present in the celiac artery which extended into the hepatic and splenic artery.As reported, the dissection was found on the previous visit.Also observed was a device ovalization (compression) of the celiac artery side branch component as it enters the celiac artery.As reported, the celiac artery component remained patent.On (b)(6) 2023, the core lab imaging (cta) dissection was still present in the celiac artery which extends into the hepatic and splenic artery.The device ovalization of the celiac artery side branch component as it enters the celiac artery remained.As reported, treatment was not required and the vbx device in the celiac artery remains patent.
|
|
Manufacturer Narrative
|
B3: event date was corrected.
|
|
Search Alerts/Recalls
|
|
|